Fungal Infections

  • Author: William G. Powderly, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 6/18/19 (What's New)

Supporting Assets

Table 1 | Table 2 | Table 3 | Table 4 | Table 5 | Table 6

Table 1. Treatment of Candidiasis in Patients With HIV[CDC OI]

First-Choice Treatment

Alternative Options

Oropharyngeal candidiasis

 

  • Clotrimazole troches 10 mg PO 5 times daily (7-14 days)
  • Miconazole mucoadhesive tablet 50 mg applied to mucosal surface over the canine fossa QD (7-14 days)
  • Itraconazole oral solution 200 mg PO daily (7-14 days)
  • Posaconazole oral suspension 400 mg PO BID for 1 day, then 400 mg daily (7-14 days)
  • Nystatin suspension 400,000-600,000 units 4-5 times daily (4-6 mL 4-5 times daily) or 1-2 lozenges 4-5 times daily (7-14 days)

Esophageal candidiasis

  • Voriconazole 200 mg PO or IV BID (14-21 days)
  • Isavuconazole (14 days)
    • 200 mg PO as a loading dose, followed by 50 mg PO QD, or
    • 400 mg PO as a loading dose, followed by 100 mg PO QD, or
    • 400 mg PO once weekly
  • Caspofungin 50 mg IV daily (14-21 days)
  • Micafungin 150 mg IV daily (14-21 days)
  • Anidulafungin 100 mg IV for 1 day, then 50 mg IV daily (14-21 days)
  • Amphotericin B deoxycholate 0.6 mg/kg IV daily (14-21 days)
  • Amphotericin B lipid complex 3-4 mg/kg IV daily

Uncomplicated vulvovaginal candidiasis

Severe or recurrent vulvovaginal candidiasis

  • Fluconazole 100-200 mg PO QD for ≥ 7 days
  • Topical antifungal for ≥ 7 days

BID, twice daily; GI, gastrointestinal; IV, intravenous; PO, orally; QD, once daily

...

Action required